Journal: Cell Reports Medicine
Article Title: Potentiating anti-tumor immunity by re-engaging immune synapse molecules
doi: 10.1016/j.xcrm.2025.101975
Figure Lengend Snippet: Reconstitution of ICAM-1/LFA-1 signaling through fusion protein Cet×ICAM1-D1 (A) Schematic structure of Cet×ICAM1-D1 fusion protein (left) and working hypothesis (right). Cet×ICAM1-D1 is composed of Fab fragment of cetuximab and murine natural D1 domain of ICAM-1, fused to a “LALA-PG” human Fc fragment. Working hypothesis: in the absence of ICAM-1, the fusion protein could interact and activate with LFA-1 signaling through the ICAM-1 D1 domain. (B) Binding affinity of cetuximab and Cet×ICAM1-D1 to EGFR in MC38 cells ( n = 3). (C and D) OT-1 T cells were co-cultured with MC38 (C) and B16F10 (D) tumor cells with serial dilutions of Cet×ICAM1-D1 or cetuximab. FACS analysis showing the percentage of intracellular IFN- γ -producing OT-I T cells ( n = 3). (E) OT-1 cells were co-cultured with SIINFEKL-pulsed or unpulsed MC38 tumor cells in the presence of 10 nM Cet×ICAM1-D1. FACS analysis showing the percentage of intracellular IFN- γ -producing OT-I T cells ( n = 3). (F) OT-I T cells were transduced with a control sgRNA (sgControl) or sgRNA targeting Cd11a . Representative FACS plot (left) and summary of mean fluorescence intensity (MFI) (right) demonstrate high knockout efficiency of Cd11a , as determined by CD11a staining ( n = 3). (G) CD11a KO or control OT-1 cells were co-cultured with MC38 tumor cells in the presence of 10 nM Cet×ICAM1-D1 or cetuximab. Representative FACS (left) and summary (right) showing the percentage of intracellular IFN- γ -producing OT1 cells in the indicated conditions ( n = 3). (H) Structure of the human version of the “LFA-1 engager,” Cet×hICAM1-D1 fusion protein. Cet×hICAM1-D1 comprises the Fab fragment of Cetuximab and the human natural D1 domain of ICAM-1, fused to a mutant “LALA-PG” human Fc fragment. (I and J) FACS analysis of intracellular IFN- γ production in NY-ESO-1-specific CTLs upon co-culture with A498 (I) and SW480 (J) tumor cells with serial dilutions of Cet×hICAM1-D1 or cetuximab ( n = 3). Data are presented as means ± SEM (B–G and I and J). ∗∗∗ p < 0.001 and ∗∗∗∗ p < 0.0001 by two-way ANOVA (B–D, G, and I and J) and unpaired Student’s t test (E and F). ns, not significant. Data are representative of at least two independent experiments (B–G and I and J).
Article Snippet: Human sgRNA library Brunello in lentiGuide-Puro , Addgene , RRID: Addgene_73178.
Techniques: Binding Assay, Cell Culture, Transduction, Control, Fluorescence, Knock-Out, Staining, Mutagenesis, Co-Culture Assay